Fiscal 2026 at a glance
In fiscal 2026 (the year to 30 June 2026), Procter & Gamble reported revenue of $87.0B, up 3.3% from fiscal 2025, and net income of $16.0B (a net margin of 18.4%).
Diluted earnings per share were $6.62.
Operating activities generated $19.6B of cash; after $4.4B of capital expenditure, free cash flow was $15.1B.
From fiscal 2017 to fiscal 2026, revenue went from $65.1B to $87.0B, a compound annual growth rate of 3.3%.
Revenue and earnings
| Fiscal year | Revenue | Growth | Net income | Net margin |
|---|---|---|---|---|
| FY202630 Jun 2026 | $87.0B | +3.3% | $16.0B | 18.4% |
| FY202530 Jun 2025 | $84.3B | +0.3% | $16.0B | 19.0% |
| FY202430 Jun 2024 | $84.0B | +2.5% | $14.9B | 17.7% |
| FY202330 Jun 2023 | $82.0B | +2.3% | $14.7B | 17.9% |
| FY202230 Jun 2022 | $80.2B | +5.3% | $14.7B | 18.4% |
| FY202130 Jun 2021 | $76.1B | +7.3% | $14.3B | 18.8% |
| FY202030 Jun 2020 | $71.0B | +4.8% | $13.0B | 18.4% |
| FY201930 Jun 2019 | $67.7B | +1.3% | $3.9B | 5.8% |
| FY201830 Jun 2018 | $66.8B | +2.7% | $9.8B | 14.6% |
| FY201730 Jun 2017 | $65.1B | — | $15.3B | 23.6% |
Cash flow and balance sheet
| Fiscal year | Operating cash flow | Capital expenditure | Free cash flow | Cash | Total assets |
|---|---|---|---|---|---|
| FY202630 Jun 2026 | $19.6B | $4.4B | $15.1B | $9.9B | $126.5B |
| FY202530 Jun 2025 | $17.8B | $3.8B | $14.0B | $9.6B | $125.2B |
| FY202430 Jun 2024 | $19.8B | $3.3B | $16.5B | $9.5B | $122.4B |
| FY202330 Jun 2023 | $16.8B | $3.1B | $13.8B | $8.2B | $120.8B |
| FY202230 Jun 2022 | $16.7B | $3.2B | $13.6B | $7.2B | $117.2B |
| FY202130 Jun 2021 | $18.4B | $2.8B | $15.6B | $10.3B | $119.3B |
| FY202030 Jun 2020 | $17.4B | $3.1B | $14.3B | $16.2B | $120.7B |
| FY201930 Jun 2019 | $15.2B | $3.3B | $11.9B | $4.2B | $115.1B |
| FY201830 Jun 2018 | $14.9B | $3.7B | $11.2B | $2.6B | $118.3B |
| FY201730 Jun 2017 | $12.8B | $3.4B | $9.4B | $5.6B | $120.4B |
How these figures are built
- Figures as reported in Procter & Gamble’s annual reports (Form 10-K), in US dollars, read from the SEC’s XBRL data. When a later report restates a year, the latest filed figure is shown.
- Free cash flow = operating cash flow − capital expenditure (purchases of property and equipment), computed by InvestIQ. Net margin = net income ÷ revenue. Compound annual growth rate: between the first and the last year of the table.
- Earnings per share are given for the latest fiscal year only: the SEC keeps each year as first filed, before any later stock split.
- Data extracted on 7 November 2026, updated after each annual report.
XBRL tags used
- Revenue
- us-gaap:Revenues
- Net income
- us-gaap:NetIncomeLoss
- Operating cash flow
- us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure
- us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Diluted earnings per share
- us-gaap:EarningsPerShareDiluted
- Total assets
- us-gaap:Assets
- Cash and equivalents
- us-gaap:CashAndCashEquivalentsAtCarryingValue
- us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Latest filings
Questions
What was Procter & Gamble’s revenue in fiscal 2026?
$87.0B for the fiscal year that ended on 30 June 2026, as reported in its 10-K annual report filed with the SEC (+3.3% year on year).
Is Procter & Gamble profitable?
In fiscal 2026, Procter & Gamble reported net income of $16.0B, a net margin of 18.4%. It reported a net profit in 10 of the last 10 fiscal years.
How much free cash flow does Procter & Gamble generate?
$15.1B in fiscal 2026, against $14.0B in fiscal 2025: operating cash flow ($19.6B) minus capital expenditure ($4.4B), two reported figures that InvestIQ subtracts.
When does Procter & Gamble’s fiscal year end?
Procter & Gamble’s fiscal year ends in June. The latest reported fiscal year ended on 30 June 2026.
Where do these figures come from?
From Procter & Gamble’s 10-K annual reports, through the SEC’s XBRL data (CIK 0000080424). They are the reported figures, in US dollars, not adjusted. This page gives no price, valuation, score or opinion.
Other companies
Reported figures, for information only. No price, valuation, score or opinion. Not investment advice.